Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT03165318
Other study ID # 2015/00276
Secondary ID
Status Enrolling by invitation
Phase N/A
First received May 23, 2017
Last updated May 23, 2017
Start date March 7, 2017
Est. completion date July 2018

Study information

Verified date May 2017
Source National University Hospital, Singapore
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a pilot study that evaluates the effect of PEMF in maintaining muscle mass postoperatively in individuals experiencing clinical immobilisation due ACL reconstruction surgery. Half of the participants will receive the PEMF therapy in combination with standard rehabilitation programme, while the other half will receive sham therapy in combination with standard rehabilitation programme.


Description:

This is a single-site, randomized, double-blinded, prospective pilot study of the effectiveness of once-weekly PEMF therapy in the promotion of muscle maintenance following ACL reconstruction surgery. Eligible subjects will be randomized in a 1:1 ratio to receive therapy with an active PEMF device or an identical inactive Sham device, in addition to the standard rehabilitation regimen.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 22
Est. completion date July 2018
Est. primary completion date July 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Subjects who have undergone unilateral first-time athroscopic reconstruction with single bundle hamstring graft using both transtibial and transportal techniques for rupture anterior cruciate ligament

- Informed consent signed

Exclusion Criteria:

- Subjects requiring concomitant knee ligament reconstruction

- Subjects having other than hamstring graft for the ACL reconstruction

- Subjects with history of cardiac, neurological, and rheumatological diseases, and previous lower limb surgery/ fracture

- Subjects with Leg circumference > 63 cm

- Pregnant women

Study Design


Related Conditions & MeSH terms

  • Muscle Loss Post Anterior Cruciate Ligament Reconstruction

Intervention

Device:
Pulsed Electromagnetic Field Therapy
Participants of this arm will be exposed to 10 minutes of Pulsed Electromagnetic Field (PEMF) once a week for a total of 16 weeks. The PEMF device produces pulsed magnetic fields at flux densities up to 1 mT peak.
Sham Therapy
Participants of this arm will be exposed to 10 minutes of sham therapy once a week for a total of 16 weeks. The Sham device is identical to the PEMF device in physical appearance.

Locations

Country Name City State
Singapore National University Health System Singapore

Sponsors (2)

Lead Sponsor Collaborator
National University Hospital, Singapore National University, Singapore

Country where clinical trial is conducted

Singapore, 

Outcome

Type Measure Description Time frame Safety issue
Primary Muscle Volume % change in muscle volume at the end of 16 weeks compared to baseline Week 1 and Week 16 post-ACL reconstruction
Secondary Quadriceps strength Quadricep strength (Ib) measurement by dynamometer Baseline and Week 8, 12, 16 post-ACL reconstruction
Secondary Knee and thigh circumference Measurement of knee girth (cm) from mid portion of the patella and thigh girth (cm) 5 cm above from the superior border of the patella Baseline and Week 1, 4, 8, 12, 16 post-ACL reconstruction
Secondary Knee Injury and Osteoarthritis Outcome Score (KOOS) Knee Injury and Osteoarthritis Outcome Score (KOOS): a validated knee-specific instrument that measures the short-term and long-term symptoms and function associated with knee injury. KOOS consists of 5 subscales: pain, other symptoms, function in daily living, function in sport and recreation, and knee related quality of life. Week 16 post-ACL reconstruction